Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Novel antithrombotic agent developed at Otsuka

Dec. 11, 1997

3-Dimensional Pharmaceuticals discloses new serine protease inhibitors

Dec. 11, 1997

Potent, orally active gpIIb/IIIa receptor antagonist for once-daily administration

Dec. 2, 1997

Toyama's antiplatelet agent progresses to clinical studies

Nov. 28, 1997

Antiplatelet and antithrombotic effects of NSL-9403

Nov. 28, 1997

FACT study results reported

Nov. 27, 1997

Expanded use approved for ReoPro in Europe

Nov. 26, 1997

NDA filed in U.S. for Otsuka antiplatelet agent

Nov. 26, 1997

Agrylin approved in Canada

Nov. 25, 1997

Lilly claims antithrombotic diamides

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...